Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Qinghai Spring Medicinal Resources Technology Co., Ltd. (600381.SS)
Xining, CN
Qinghai Spring Medicinal Resources Technology Co., Ltd. specializes in the research, development, and commercialization of cordyceps products. Its operations further extend to the distribution of beverages and aquatic items, providing advertising solutions, and conducting foreign investment activities. The company was established in 2003 and is headquartered in Xining, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.97% | +4.97% | +16.94% | +2.28% | -26.43% | -18.96% | +10.12% | -60.85% | -42.83% | -76.33% | -79.13% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Coal: -9.5%+27.1% ★ Q1'26: -47.6% (vs Q1'25)
-
EPS growth Coal: -15.8%+79.4% ★ Q1'26: -288.5% (vs Q1'25)
-
FCF margin FCF growth · Coal: +4.7%-18.6% Q1'26: -44.4% (vs Q1'25)
-
EBIT margin Coal: +10.5%-7.2% Q1'26: -37.0% (vs Q1'25)
-
ROIC Coal: +3.2%-3.0% Q1'26: -7.9% (vs Q1'25)
-
Share dilution Coal: +0.0%-8.8% ★ Q1'26: -3.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Coal: -0.13×3.51× ★ Q1'26: -0.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
|---|---|---|
| Revenue |
333.02M
est: 782.72M (-57.5%)
|
233.75M
est: 1.32B (-82.2%)
|
| EBITDA |
105.90M
est: -692.33M (+115.3%)
|
38.74M
est: -1.16B (+103.3%)
|
| EBIT |
63.66M
est: -742.33M (+108.6%)
|
-1.57M
est: -1.25B (+99.9%)
|
| Net Income |
68.45M
|
5.81M
|
| SGA |
138.90M
est: 524.49M (-73.5%)
|
105.20M
est: 881.83M (-88.1%)
|
| EPS |
0.12
|
0.01
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ding Chen | Deputy GM, Board Secretary & Director | — | male |
| Lingxiao Liu | Deputy General Manager | — | female |
| Tiepeng Yao | Deputy GM & Director | — | male |
| Wang Lin | Financial Director & Accounting Supervisor | — | female |
| Xuefeng Zhang | Chairman & GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600381.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
